ArticleAddiction neuroscience2026
The central amygdala corticotropin releasing factor system regulates anxiety-like behavior in an age- and sex- dependent manner in rats.
Article in Addiction neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Moderate prenatal alcohol exposure differentially alters acute ethanol sensitivity of GABAergic transmission in CRFR1- and CRFR1+ CeM Neurons.Addiction neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The corticotropin releasing factor (CRF) system is a key regulator of anxiety-like behavior and a major contributor to addiction. The canonical anxiogenic role of CRF has been largely based on CRF manipulations in adult male rodents, particularly within the central amygdala (CeA), despite evidence that underlying neurobiological mechanisms of anxiety are sex- and age-dependent. Our lab has shown that the physiological response to CRF receptor 1 (CRFR1) activation within the medial CeA, a brain region associated with anxiety and addiction, varies with both age and sex. Therefore, in the current study, we investigated the effects of CRFR1 activation in the CeA on anxiety-like behavior in naïve juvenile (~postnatal day [P] 25), adolescent (~P45), or adult (~P80) male and female Sprague Dawley rats. Rats were given bilateral cannula in the CeA and then tested in the light-dark box test following an infusion of either the CRFR1 agonist Stressin-1 (1 μM) or vehicle. In contrast to the previously established anxiogenic effects of CRF agonists, we found that intra-CeA Stressin-1 decreased anxiety-like behavior in females regardless of age and juvenile males, with no significant effects evident in adolescent or adult males. Notably, RNAscope
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.